Media kit: Neurological innovation

Oregon Health & Science University provides a curated selection of high-resolution photos, video footage, b-roll and graphics for news organizations and media coverage related to OHSU stories. Commercial use is prohibited without prior written consent.

Media usage guidelines

  • Photos and video should be credited as “OHSU/Photographer name.”
  • Metadata includes captions and usage restrictions.
  • Color correction and cropping are allowed. The content or nature of the photo may not be altered.

Questions or requests: Please contact OHSU Strategic Communications at news@ohsu.edu or 503-494-8231.

Dystroglycanopathy protein discovery
Dystroglycanopathy protein discovery
Researchers in the lab of Kevin Wright, Ph.D., at Oregon Health & Science University identified a key protein involved in brain synapse development, offering new insight into the neurological effects of a rare form of muscular dystrophy known as dystroglycanopathy. (OHSU/Christine Torres Hicks)
OHSU Balance Disorder Lab studies movement in Parkinson’s patients
OHSU Balance Disorder Lab studies movement in Parkinson’s patients
A patient demonstrates an OHSU training protocol designed to improve turning ability for people with Parkinson’s disease at the OHSU Balance Disorder Lab. A first-of-its-kind clinical trial uses wearable sensors to evaluate whether targeted exercise can improve mobility, reduce falls and enhance quality of life. (OHSU/Christine Torres Hicks)
Clearing brain waste
Clearing brain waste

Researchers at Oregon Health & Science University used imaging in neurosurgery patients to reveal, for the first time, waste-clearing pathways in the human brain known as the glymphatic system, offering new insight into how the brain removes waste and how lifestyle factors may support brain health. (OHSU/Christine Torres Hicks)

OHSU grows neuro-oncology expertise for patient benefit
OHSU grows neuro-oncology expertise for patient benefit
OHSU’s departments of Neurology and Neurological Surgery, alongside the OHSU Knight Cancer Institute, collaborate to deliver advanced clinical care, innovative clinical trials and cutting-edge research for patients with brain, spine and other central nervous system tumors. (OHSU/Christine Torres Hicks)
The path to being seizure-free
The path to being seizure-free

Annette Adkins walks in her Portland neighborhood after receiving investigational regenerative brain cell therapy for epilepsy at OHSU. The treatment is part of a multisite clinical trial of NRTX-1001. (OHSU/Christine Torres Hicks)